喜报！盟科药业再次获得高新技术企业资质认定

Core Viewpoint - Shanghai Amcare Pharmaceutical Co., Ltd. has successfully passed the re-evaluation for the high-tech enterprise qualification, reflecting its strong R&D capabilities and innovative potential [1][2] Group 1: High-Tech Enterprise Qualification - The company has been re-certified as a high-tech enterprise, which is a significant recognition of its R&D investment, technology transformation capabilities, and core intellectual property [1] - The re-evaluation standards for high-tech enterprises are stricter than those for new applications, focusing on the integration of technological innovation with core business and sustainable development potential [1] Group 2: Company Commitment and Future Plans - The company emphasizes "innovation-driven" as its core strategy and acknowledges the collective effort of its employees and support from government and industry partners in achieving this recognition [2] - Future plans include enhancing R&D efficiency, improving the innovation system, and strengthening core technology reserves to provide better products and services to the market [2] - The company aims to fulfill its social responsibilities as a high-tech enterprise by continuing to innovate in the biopharmaceutical field and contributing to industry progress and local economic growth [2]